(Q45425500)

English

Safety and immunogenicity of conventional subunit and MF59-adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patients

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Safety and immunogenicity of conventional subunit and MF59-adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

author name string

G Gabutti

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

M Guido

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

P Durando

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

A De Donno

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

M Quattrocchi

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

S Bacilieri

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

F Ansaldi

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

S Cataldini

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

P G Chiriacò

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

M De Simone

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

S Minniti

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

L Sticchi

12

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

R Gasparini

13

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Journal of International Medical Research

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

406-416

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Influenza-associated morbidity and mortality in young and middle-aged women

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Influenza, influenza virus vaccine, and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Effect of influenza vaccination on disease progression among HIV-infected persons

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Activation of virus replication after vaccination of HIV-1-infected individuals.

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Dynamics of HIV-1 replication following influenza vaccination of HIV+ individuals

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Comparison of the effects of acute influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Immunogenicity of influenza vaccine (1993–1994 winter season) in HIV-seropositive and -seronegative ex-intravenous drug users

1 reference

https://api.crossref.org/works/10.1177%2F147323000503300406

21 January 2018

Identifiers

10.1177/147323000503300406

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45425500&oldid=2076940981"